Health IT Analytics January 8, 2021
Researchers have identified and characterized three molecular subtypes of Alzheimer’s disease, which could accelerate development of precision medicine therapies.
Using data from RNA sequencing, a team from the Icahn School of Medicine at Mount Sinai has detected three molecular subtypes of Alzheimer’s disease that could advance precision medicine treatments for the condition.
Alzheimer’s is the most common form of dementia, but it ranges in its biological and pathological manifestations. Researchers noted that there is a growing body of evidence suggesting that disease progression and responses to interventions differ significantly among Alzheimer’s patients.
While some patients have slow cognitive decline, others decline rapidly; some have significant memory loss and an inability to remember new information while others don’t; and some patients...
Today's Sponsors
Today's Sponsor